for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Relief Therapeutics And NeuroRx Expand Trial Of RLF-100 In COVID-19 Patients

June 11 (Reuters) - RELIEF THERAPEUTICS HOLDING SA:

* RELIEF THERAPEUTICS AND NEURORX EXPAND CLINICAL TRIAL EVALUATING RLF-100 IN CRITICALLY ILL COVID-19 PATIENTS WITH RESPIRATORY FAILURE TO HOUSTON METHODIST HOSPITAL

* CLINICAL TRIAL TO ENROLL 144 PATIENTS TOTAL WITH EXPANSION TO ADDITIONAL SITES Source text: bit.ly/2MKzNEs Further company coverage: (Gdansk Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up